XML 111 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Stockholders' Deficit (USD $)
In Thousands, except Share data
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total
Beginning balances at Dec. 31, 2010    $ 67 $ 798,840 $ 1 $ (954,183) $ (155,275)
Beginning balances, shares at Dec. 31, 2010    66,986,940        
Stock options exercised     1,130     1,130
Stock options exercised, shares   257,435        
Compensation expense on share-based awards     4,100     4,100
Net proceeds from sale of shares   13 107,020     107,033
Net proceeds from sale of shares, shares   12,687,065        
Conversion of 5.75% convertible notes   6 33,254     33,260
Conversion of 5.75% convertible notes, shares   6,149,727        
Other comprehensive income (loss)       (97)   (97)
Net loss         (36,267) (36,267)
Ending balances at Dec. 31, 2011    86 944,344 (96) (990,450) (46,116)
Ending balances, shares at Dec. 31, 2011    86,081,167        
Stock options exercised   1 2,407     2,408
Stock options exercised, shares   481,058        
Shares issued for services rendered     149     149
Shares issued for services rendered, shares   171,271        
Compensation expense on share-based awards     7,298     7,298
Net proceeds from sale of shares     254     254
Net proceeds from sale of shares, shares   45,553        
Other comprehensive income (loss)       101   101
Net loss         (18,735) (18,735)
Ending balances at Dec. 31, 2012    87 954,452 5 (1,009,185) (54,641)
Ending balances, shares at Dec. 31, 2012    86,779,049        
Stock options exercised   3 14,528     14,531
Stock options exercised, shares   2,521,764       (2,522,000)
Restricted stock vesting   0 339     339
Restricted stock vesting, shares   211,389        
Compensation expense on share-based awards     8,480     8,480
Excess tax benefit from stock options     178     178
Stock issued in connection with the Takeda Termination and Transition agreement   6 55,397     55,403
Stock issued in connection with the Takeda Termination and Transition agreement, shares   6,128,641        
Net proceeds from sale of shares   7 94,046     94,053
Net proceeds from sale of shares, shares   6,972,937        
Other comprehensive income (loss)       51   51
Net loss         (13,504) (13,504)
Ending balances at Dec. 31, 2013    $ 103 $ 1,127,420 $ 56 $ (1,022,689) $ 104,890
Ending balances, shares at Dec. 31, 2013    102,613,780